space space   
 

Essais achevés

GX15-070       
Protocole GX001

A Single-Center, Open-Label, Phase I Study of Weekly, Single-Agent GX15-070MS in Solid Tumors
 
   
GX15-070             
Protocole GX004

A Multi-Center, Open-Label, Phase I/II Study of Single-Agent GX15-070MS Administered Every 2 to 3 Weeks to Patients with Previously-Treated Chronic Lymphocytic Leukemia (CLL)
Liens  
PMID: 17157163 - Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells. Exp Hematol. 2006 Dec;34(12):1663-9
Small Molecule Pan-Bcl2 Family Inhibitor Obatoclax (GX15-070): Overview of Clinical Phase I Study Results. Chemotherapy Foundation Symposium 2006
 
 
GX15-070       
Protocole GX005

A Multi-Center, Open-Label, Phase I Study of Weekly, Single-Agent GX15-070MS Administered as a 3-Hour Infusion in Patients with Refractory Solid Tumors or Lymphomas
Liens  
A Phase I Study of the Pan-Bcl2 Family Inhibitor GX15-070, Administered as a 3-hour Weekly Infusion in Patients with Refractory Solid Tumors or Lymphomas. ASCO 2006
Small Molecule Pan-Bcl2 Family Inhibitor Obatoclax (GX15-070): Overview of Clinical Phase I Study Results. Chemotherapy Foundation Symposium 2006